Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release

Patients whose blood is deficient in the terminal component of complement have an increased susceptibility to meningococcal infection. However, mortality from meningococcal infection is lower in these patients than in immunocompetent subjects. We studied a C6-deficient patient with meningococcal sep...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 1992-12, Vol.340 (8832), p.1379-1381
Hauptverfasser: Lehner, P.J., Cohen, J., Davies, K.A., Walport, M.I., Cape, A.P., Wurzner, R., Orren, A., Morgan, B.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1381
container_issue 8832
container_start_page 1379
container_title The Lancet (British edition)
container_volume 340
creator Lehner, P.J.
Cohen, J.
Davies, K.A.
Walport, M.I.
Cape, A.P.
Wurzner, R.
Orren, A.
Morgan, B.P.
description Patients whose blood is deficient in the terminal component of complement have an increased susceptibility to meningococcal infection. However, mortality from meningococcal infection is lower in these patients than in immunocompetent subjects. We studied a C6-deficient patient with meningococcal sepsis who received fresh frozen plasma (FFP). The patient's initial plasma endotoxin, C6, and terminal-complement-complex concentrations were low, but rose sharply after treatment with FFP. Samples of the patient's serum taken shortly after admission did not cause endotoxin release from Escherichia coli J5 in vitro, but endotoxin-releasing activity was restored in serum samples taken after infusion of FFP. It is possible that C6-deficient patients have reduced mortality from meningococcal infection because their serum cannot cause acute release of endotoxin from the invading organism and extensive tissue damage is thus avoided.
doi_str_mv 10.1016/0140-6736(92)92561-S
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73351620</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>014067369292561S</els_id><sourcerecordid>73351620</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-a9f29895cf3dded60a7fc6ddf8466b41606056dc9986992d33095597ab35250e3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoO4rOPqP1AIHkQPveajk55cBBn8gl08rIK3UJNUNEt30ibdwv77zewsCh6EgjrUU1_vS8gzzs454_oN4z3r9CD1KyNeG6E0764ekA3vh75T_fD9Idn8QR6Rx7VeM8Z6zdQpOeVSM2b4htRLTDH9yC47ByOtOC_RAU4RaEwU6E53HkN0EdNCZ1juMiRPMQR0S6U50HmEOgFdCqQa1hpzoi3GOOc5jzcVnPsJJXqkBUeEik_ISYCx4tP7fEa-fXj_dfepu_jy8fPu3UXnhDFLByYIszXKBek9es1gCE57H7a91vuea9Z-0d4Zs9XGCC8lM0qZAfZSCcVQnpGXx7lzyb9WrIudYnU4jpAwr9UOUiquBWvgi3_A67yW1G6zvF1guBGiQf0RciXXWjDYucQJyo3lzB4MsQe17UFta4S9M8Retbbn97PX_YT-b9PRgVZ_e6xjU-J3xGLrQWyHPpYmsPU5_n_BLZIomvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198991922</pqid></control><display><type>article</type><title>Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Business Source Complete</source><creator>Lehner, P.J. ; Cohen, J. ; Davies, K.A. ; Walport, M.I. ; Cape, A.P. ; Wurzner, R. ; Orren, A. ; Morgan, B.P.</creator><creatorcontrib>Lehner, P.J. ; Cohen, J. ; Davies, K.A. ; Walport, M.I. ; Cape, A.P. ; Wurzner, R. ; Orren, A. ; Morgan, B.P.</creatorcontrib><description>Patients whose blood is deficient in the terminal component of complement have an increased susceptibility to meningococcal infection. However, mortality from meningococcal infection is lower in these patients than in immunocompetent subjects. We studied a C6-deficient patient with meningococcal sepsis who received fresh frozen plasma (FFP). The patient's initial plasma endotoxin, C6, and terminal-complement-complex concentrations were low, but rose sharply after treatment with FFP. Samples of the patient's serum taken shortly after admission did not cause endotoxin release from Escherichia coli J5 in vitro, but endotoxin-releasing activity was restored in serum samples taken after infusion of FFP. It is possible that C6-deficient patients have reduced mortality from meningococcal infection because their serum cannot cause acute release of endotoxin from the invading organism and extensive tissue damage is thus avoided.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/0140-6736(92)92561-S</identifier><identifier>PMID: 1360091</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Bacteremia - immunology ; Bacteremia - mortality ; Blood ; Blood Bactericidal Activity ; Blood Component Transfusion ; Complement C6 - deficiency ; Complement Membrane Attack Complex - immunology ; E coli ; Endotoxins ; Endotoxins - metabolism ; Escherichia coli - metabolism ; Female ; Humans ; Lipopolysaccharides - blood ; Medical research ; Meningitis, Meningococcal - immunology ; Meningitis, Meningococcal - mortality ; Mortality ; Neisseria meningitidis - immunology ; Plasma</subject><ispartof>The Lancet (British edition), 1992-12, Vol.340 (8832), p.1379-1381</ispartof><rights>1992</rights><rights>Copyright Lancet Ltd. Dec 5, 1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-a9f29895cf3dded60a7fc6ddf8466b41606056dc9986992d33095597ab35250e3</citedby><cites>FETCH-LOGICAL-c299t-a9f29895cf3dded60a7fc6ddf8466b41606056dc9986992d33095597ab35250e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/014067369292561S$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1360091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lehner, P.J.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Davies, K.A.</creatorcontrib><creatorcontrib>Walport, M.I.</creatorcontrib><creatorcontrib>Cape, A.P.</creatorcontrib><creatorcontrib>Wurzner, R.</creatorcontrib><creatorcontrib>Orren, A.</creatorcontrib><creatorcontrib>Morgan, B.P.</creatorcontrib><title>Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Patients whose blood is deficient in the terminal component of complement have an increased susceptibility to meningococcal infection. However, mortality from meningococcal infection is lower in these patients than in immunocompetent subjects. We studied a C6-deficient patient with meningococcal sepsis who received fresh frozen plasma (FFP). The patient's initial plasma endotoxin, C6, and terminal-complement-complex concentrations were low, but rose sharply after treatment with FFP. Samples of the patient's serum taken shortly after admission did not cause endotoxin release from Escherichia coli J5 in vitro, but endotoxin-releasing activity was restored in serum samples taken after infusion of FFP. It is possible that C6-deficient patients have reduced mortality from meningococcal infection because their serum cannot cause acute release of endotoxin from the invading organism and extensive tissue damage is thus avoided.</description><subject>Adult</subject><subject>Bacteremia - immunology</subject><subject>Bacteremia - mortality</subject><subject>Blood</subject><subject>Blood Bactericidal Activity</subject><subject>Blood Component Transfusion</subject><subject>Complement C6 - deficiency</subject><subject>Complement Membrane Attack Complex - immunology</subject><subject>E coli</subject><subject>Endotoxins</subject><subject>Endotoxins - metabolism</subject><subject>Escherichia coli - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Lipopolysaccharides - blood</subject><subject>Medical research</subject><subject>Meningitis, Meningococcal - immunology</subject><subject>Meningitis, Meningococcal - mortality</subject><subject>Mortality</subject><subject>Neisseria meningitidis - immunology</subject><subject>Plasma</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kU2LFDEQhoO4rOPqP1AIHkQPveajk55cBBn8gl08rIK3UJNUNEt30ibdwv77zewsCh6EgjrUU1_vS8gzzs454_oN4z3r9CD1KyNeG6E0764ekA3vh75T_fD9Idn8QR6Rx7VeM8Z6zdQpOeVSM2b4htRLTDH9yC47ByOtOC_RAU4RaEwU6E53HkN0EdNCZ1juMiRPMQR0S6U50HmEOgFdCqQa1hpzoi3GOOc5jzcVnPsJJXqkBUeEik_ISYCx4tP7fEa-fXj_dfepu_jy8fPu3UXnhDFLByYIszXKBek9es1gCE57H7a91vuea9Z-0d4Zs9XGCC8lM0qZAfZSCcVQnpGXx7lzyb9WrIudYnU4jpAwr9UOUiquBWvgi3_A67yW1G6zvF1guBGiQf0RciXXWjDYucQJyo3lzB4MsQe17UFta4S9M8Retbbn97PX_YT-b9PRgVZ_e6xjU-J3xGLrQWyHPpYmsPU5_n_BLZIomvc</recordid><startdate>19921205</startdate><enddate>19921205</enddate><creator>Lehner, P.J.</creator><creator>Cohen, J.</creator><creator>Davies, K.A.</creator><creator>Walport, M.I.</creator><creator>Cape, A.P.</creator><creator>Wurzner, R.</creator><creator>Orren, A.</creator><creator>Morgan, B.P.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19921205</creationdate><title>Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release</title><author>Lehner, P.J. ; Cohen, J. ; Davies, K.A. ; Walport, M.I. ; Cape, A.P. ; Wurzner, R. ; Orren, A. ; Morgan, B.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-a9f29895cf3dded60a7fc6ddf8466b41606056dc9986992d33095597ab35250e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adult</topic><topic>Bacteremia - immunology</topic><topic>Bacteremia - mortality</topic><topic>Blood</topic><topic>Blood Bactericidal Activity</topic><topic>Blood Component Transfusion</topic><topic>Complement C6 - deficiency</topic><topic>Complement Membrane Attack Complex - immunology</topic><topic>E coli</topic><topic>Endotoxins</topic><topic>Endotoxins - metabolism</topic><topic>Escherichia coli - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Lipopolysaccharides - blood</topic><topic>Medical research</topic><topic>Meningitis, Meningococcal - immunology</topic><topic>Meningitis, Meningococcal - mortality</topic><topic>Mortality</topic><topic>Neisseria meningitidis - immunology</topic><topic>Plasma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lehner, P.J.</creatorcontrib><creatorcontrib>Cohen, J.</creatorcontrib><creatorcontrib>Davies, K.A.</creatorcontrib><creatorcontrib>Walport, M.I.</creatorcontrib><creatorcontrib>Cape, A.P.</creatorcontrib><creatorcontrib>Wurzner, R.</creatorcontrib><creatorcontrib>Orren, A.</creatorcontrib><creatorcontrib>Morgan, B.P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lehner, P.J.</au><au>Cohen, J.</au><au>Davies, K.A.</au><au>Walport, M.I.</au><au>Cape, A.P.</au><au>Wurzner, R.</au><au>Orren, A.</au><au>Morgan, B.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>1992-12-05</date><risdate>1992</risdate><volume>340</volume><issue>8832</issue><spage>1379</spage><epage>1381</epage><pages>1379-1381</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Patients whose blood is deficient in the terminal component of complement have an increased susceptibility to meningococcal infection. However, mortality from meningococcal infection is lower in these patients than in immunocompetent subjects. We studied a C6-deficient patient with meningococcal sepsis who received fresh frozen plasma (FFP). The patient's initial plasma endotoxin, C6, and terminal-complement-complex concentrations were low, but rose sharply after treatment with FFP. Samples of the patient's serum taken shortly after admission did not cause endotoxin release from Escherichia coli J5 in vitro, but endotoxin-releasing activity was restored in serum samples taken after infusion of FFP. It is possible that C6-deficient patients have reduced mortality from meningococcal infection because their serum cannot cause acute release of endotoxin from the invading organism and extensive tissue damage is thus avoided.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>1360091</pmid><doi>10.1016/0140-6736(92)92561-S</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 1992-12, Vol.340 (8832), p.1379-1381
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_73351620
source MEDLINE; Elsevier ScienceDirect Journals Complete; Business Source Complete
subjects Adult
Bacteremia - immunology
Bacteremia - mortality
Blood
Blood Bactericidal Activity
Blood Component Transfusion
Complement C6 - deficiency
Complement Membrane Attack Complex - immunology
E coli
Endotoxins
Endotoxins - metabolism
Escherichia coli - metabolism
Female
Humans
Lipopolysaccharides - blood
Medical research
Meningitis, Meningococcal - immunology
Meningitis, Meningococcal - mortality
Mortality
Neisseria meningitidis - immunology
Plasma
title Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meningococcal%20septicaemia%20in%20a%20C6-deficient%20patient%20and%20effects%20of%20plasma%20transfusion%20on%20lipopolysaccharide%20release&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Lehner,%20P.J.&rft.date=1992-12-05&rft.volume=340&rft.issue=8832&rft.spage=1379&rft.epage=1381&rft.pages=1379-1381&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/0140-6736(92)92561-S&rft_dat=%3Cproquest_cross%3E73351620%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=198991922&rft_id=info:pmid/1360091&rft_els_id=014067369292561S&rfr_iscdi=true